Gene Symbol,Gene Aliases,Protein Name,Total Interactions,Number of Reports
ABAT,GABAT; NPD009; GABA-AT,4-aminobutyrate aminotransferase,11,7,
ACTN4,FSGS; FSGS1; ACTININ-4,"actinin, alpha 4",8,6,
ADA,Adenosine aminohydrolase,adenosine deaminase,13,9,
ADCY5,ATP pyrophosphate-lyase 5; Adenylate cyclase type V; Adenylyl cyclase 5; AC5,Adenylate cyclase type 5,1,1,
ADK,AK,adenosine kinase,6,5,
ADNP,ADNP1,activity-dependent neuroprotector homeobox,51,21,
ADORA2A,RDC8; hA2aR; ADORA2,adenosine A2a receptor,15,8,
ADRB2,"ADRB2R, ADRBR, B2AR, BAR, BETA2AR","adrenergic, beta-2-, receptor, surface",194,27,
ADSL,"RP5-1042K10.8, AMPS, ASASE, ASL",adenylosuccinate lyase,17,7,
AFF2,FMR2; MRX2; OX19; FMR2P; FRAXE,"AF4/FMR2 family, member 2",3,3,
AFF4,MCEF; AF5Q31,"AF4/FMR2 family, member 4",37,6,
AGAP1,"CENTG2, GGAP1, KIAA1099, MGC71657","ArfGAP with GTPase domain, ankyrin repeat and PH domain 1",15,6,
AGBL4,CCP6,ATP/GTP binding protein-like 4,1,1,
AGTR2,"AT2, ATGR2, MRX88","angiotensin II receptor, type 2",2,2,
AHI1,"RP1-32B1.2, AHI-1, DKFZp686J1653, FLJ14023, FLJ20069, JBTS3, ORF1, dJ71N10.1",Abelson helper integration site 1,6,6,
ALDH5A1,"SSADH, SSDH","aldehyde dehydrogenase 5 family, member A1",8,4,
ANK2,"DKFZp686M09125, DKFZp686P0948, FLJ38277, LQT4","ankyrin 2, neuronal",36,16,
ANK3,"RP11-369L1.1, ANKYRIN-G, FLJ45464","ankyrin 3, node of Ranvier (ankyrin G)",57,33,
ANKRD11,"ANCO-1, ANCO1, LZ16, T13",ankyrin repeat domain 11,30,9,
ANXA1,"RP11-71A24.1, ANX1, LPC1",annexin A1,55,30,
APBA2,X11L; MINT2; LIN-10; HsT16821; X11-BETA; D15S1518E; MGC:14091,"amyloid beta (A4) precursor protein-binding, family A, member 2",32,13,
APC,"BTPS2, DP2, DP2.5, DP3, GS",adenomatous polyposis coli,391,36,
APH1A,APH-1; APH-1A; CGI-78; 6530402N02Rik,anterior pharynx defective 1 homolog A (C. elegans),2,1,
APP,"AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN2",amyloid beta (A4) precursor protein,79,16,
AR,KD; AIS; TFM; DHTR; SBMA; HYSP1; NR3C4; SMAX1; HUMARA,androgen receptor,19,16,
ARHGAP32,GRIT; RICS; GC-GAP; PX-RICS; p250GAP; p200RhoGAP,Rho GTPase activating protein 32,9,4,
Arhgap33,Rho-type GTPase-activating protein 33; Sorting nexin-26; Tc10/CDC42 GTPase-activating protein,Rho GTPase-activating protein 33,5,2,
ARHGEF9,PEM2; EIEE8; PEM-2; HPEM-2; COLLYBISTIN,Cdc42 guanine nucleotide exchange factor (GEF) 9,3,3,
ARID1B,OSA2; 6A3-5; DAN15; MRD12; P250R; BRIGHT; BAF250B; ELD/OSA1; KIAA1235,AT rich interactive domain 1B (SWI1-like),27,13,
ARNT2,bHLHe1,aryl-hydrocarbon receptor nuclear translocator 2,297,17,
ARX,"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS",aristaless related homeobox,1010,10,
ASH1L,ASH1; KMT2H; ASH1L1,"ash1 (absent, small, or homeotic)-like (Drosophila)",21,15,
ASTN2,"RP11-45A16.2, KIAA0634, bA67K19.1",astrotactin 2,4,4,
ASXL3,KIAA1713,additional sex combs like 3 (Drosophila),2,2,
ATP10A,ATPase class V type 10A,"ATPase, class V, type 10A",1,1,
ATP1A3,"AHC2, ATP1A1, CAPOS, DYT12, RDP",ATPase Na+/K+ transporting subunit alpha 3,9,6,
ATP2B2,PMCA2; PMCA2a; PMCA2i,"ATPase, Ca++ transporting, plasma membrane 2",121,17,
ATP8A1,ATPIA; ATPP2; ATPASEII,"ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1",4,3,
ATRNL1,ALP; bA338L11.1; bA454H24.1,attractin-like 1,1,1,
ATRX,"RP5-875J14.1, ATR2, MGC2094, MRXHF1, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX",alpha thalassemia/mental retardation syndrome X-linked,7,5,
ATXN7,SCA7; OPCA3; ADCAII,ataxin 7,3,2,
AUTS2,MRD26; FBRSL2,Autism susceptibility gene 2 protein,143,8,
AVPR1A,"AVPR V1a, AVPR1, V1aR",arginine vasopressin receptor 1A,3,2,
BAIAP2,BAP2; FLAF3; IRSP53,BAI1-associated protein 2,22,7,
BCKDK,"Branched-chain alpha-ketoacid dehydrogenase kinase, BCKD-kinase",branched chain ketoacid dehydrogenase kinase,23,9,
BCL11A,"BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, FLJ10173, FLJ34997, HBFQTL5, KIAA1809, ZNF856",B-cell CLL/lymphoma 11A (zinc finger protein),42,18,
BDNF,"Abrineurin, BDNF",brain-derived neurotrophic factor,9,4,
BIN1,"AMPH2, AMPHL, DKFZp547F068, MGC10367, SH3P9",bridging integrator 1,10,3,
BIRC6,BRUCE; APOLLON,baculoviral IAP repeat containing 6,22,4,
BRAF,Proto-oncogene B-Raf,Serine/threonine-protein kinase B-raf,21,3,
BRCA2,"RP11-298P3.4, BRCC2, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, GLM3, PNCA2","breast cancer 2, early onset",84,48,
BZRAP1,"DKFZp686F02123, KIAA0612, PRAX-1, PRAX1, RIM-BP1, RIMBP1",benzodiazapine receptor (peripheral) associated protein 1,22,6,
c-Met,"HGF/SF receptor, HGF receptor",Hepatocyte growth factor receptor,59,2,
C15orf43,,Uncharacterized protein C15orf43,1,1,
C3orf58,"DIA1, MGC33365",chromosome 3 open reading frame 58,5,3,
C4B,CH; C4F; CO4; C4B1; C4B2; C4B3; C4B5; C4BD; C4B12; C4B_2; CPAMD3,complement component 4B (Chido blood group),10,9,
CA6,Carbonate dehydratase VI; Carbonic anhydrase VI; CA-VI; Salivary carbonic anhydrase; Secreted carbonic anhydrase,Carbonic anhydrase 6,7,4,
CACNA1C,"CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS","calcium channel, voltage-dependent, L type, alpha 1C subunit",48,28,
CACNA1E,BII; Cach6; Cav2.3; Cchra1; alpha1E; Cacnl1a6; A430040I15,"calcium channel, voltage-dependent, R type, alpha 1E subunit",2,2,
CACNA1F,Voltage-gated calcium channel subunit alpha Cav1.4,Voltage-dependent L-type calcium channel subunit alpha-1F,6,4,
CACNA1G,"Ca(V)T.1, Cav3.1, NBR13","calcium channel, voltage-dependent, T type, alpha 1G subunit",9,8,
CACNA1H,"CACNA1HB, Cav3.2, ECA6, EIG6, FLJ90484","calcium channel, voltage-dependent, T type, alpha 1H subunit",14,12,
CACNB2,"RP11-383B4.2, CACNLB2, CAVB2, FLJ23743, MYSB","calcium channel, voltage-dependent, beta 2 subunit",7,5,
CADM1,"BL2, DKFZp686F1789, IGSF4, IGSF4A, MGC149785, MGC51880, NECL2, Necl-2, RA175, ST17, SYNCAM, TSLC1, sTSLC-1, sgIGSF, synCAM1",cell adhesion molecule 1,22,17,
CADPS2,"Calcium-dependent activator protein for secretion 2, CAPS-2",Ca++-dependent secretion activator 2,18,9,
CAPRIN1,M11S1; GPIAP1; RNG105; GPIP137; p137GPI,cell cycle associated protein 1,4,4,
CASC4,H63,cancer susceptibility candidate 4,9,7,
CC2D1A,MRT3; FREUD-1; Freud-1/Aki1,coiled-coil and C2 domain containing 1A,13,9,
CD44,"CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1",CD44 molecule (Indian blood group),53,5,
CDC42BPB,MRCKB,CDC42 binding protein kinase beta (DMPK-like),8,3,
CDH10,T2-cadherin,"cadherin 10, type 2 (T2-cadherin)",9,6,
CDH11,"OSF-4, OB-cadherin",Cadherin-11,2,1,
CDH22,"Pituitary and brain cadherin, PB-cadherin",PB-cadherin,1,1,
CDH8,Nbla04261,"cadherin 8, type 2",20,3,
CDH9,,Cadherin-9,8,3,
CDKL5,"RP1-245G19.3, ISSX, STK9",cyclin-dependent kinase-like 5,23,13,
CHD2,"ATP-dependent helicase CHD2, CHD-2",chromodomain helicase DNA binding protein 2,47,12,
CHD7,IS3; KAL5; FLJ20357; FLJ20361; KIAA1416,chromodomain helicase DNA binding protein 7,110,16,
CHD8,HELSNF1; KIAA1564; DKFZp686N17164,chromodomain helicase DNA binding protein 8,4376,15,
CHORDC1,CHP1,cysteine and histidine-rich domain (CHORD) containing 1,17,8,
CHRNA7,NACHRA7; CHRNA7-2,"cholinergic receptor, nicotinic, alpha 7 (neuronal)",17,9,
CLSTN3,CSTN3; CDHR14; alcbeta,calsyntenin 3,6,4,
CLTCL1,"CHC22, CLH22, CLTCL, CLTD","clathrin, heavy chain-like 1",39,9,
CMIP,TCMIP,c-Maf inducing protein,4,4,
CNR1,"CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR",cannabinoid receptor 1 (brain),1,1,
CNTN4,"AXCAM, BIG-2, CNTN4A, MGC33615",contactin 4,6,6,
CNTN6,NB3,contactin 6,3,1,
CNTNAP2,"AUTS15, CASPR2, CDFE, DKFZp781D1846, NRXN4, PTHSL1",contactin associated protein-like 2,44,16,
CNTNAP4,Cell recognition molecule Caspr4,Contactin-associated protein-like 4,6,2,
CNTNAP5,caspr5,contactin associated protein-like 5,1,1,
CREBBP,"CBP, KAT3A, RSTS",CREB binding protein,18,12,
CSNK1D,HCKID,"casein kinase 1, delta",55,27,
CTCF,11-zinc finger protein,CCCTC-binding factor (zinc finger protein),54,26,
CTNNA3,VR22,"catenin (cadherin-associated protein), alpha 3",33,6,
CTNNB1,CTNNB; FLJ25606; FLJ37923; DKFZp686D02253,"catenin (cadherin-associated protein), beta 1, 88kDa",235,155,
CTNND2,GT24; NPRAP,"catenin (cadherin-associated protein), delta 2",99,44,
CTTNBP2,"C7orf8, CORTBP2, Orf4",cortactin binding protein 2,27,7,
CUL3,CUL-3; PHA2E,cullin 3,1281,63,
CYP11B1,"CPN1, CYP11B, FHI, P450C11","cytochrome P450, family 11, subfamily B, polypeptide 1",4,4,
DAPK1,"DAPK, DKFZp781I035",death-associated protein kinase 1,4,3,
DCUN1D1,RP42; SCRO; Tes3; DCNL1; SCCRO; DCUN1L1,"DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae)",12,4,
DCX,"DBCN, DC, LISX, SCLH, XLIS",doublecortin,19,4,
DDX53,"CAGE, CT26",DEAD (Asp-Glu-Ala-Asp) box polypeptide 53,5,3,
DEAF1,SPN; NUDR; ZMYND5,DEAF1 transcription factor,25,13,
DENR,DRP; DRP1; SMAP-3,density-regulated protein,32,2,
DGCR8,Gy1; pasha; DGCRK6; C22orf12,DiGeorge syndrome critical region gene 8,7,5,
DGKZ,DAGK5; DAGK6; DGK-ZETA; hDGKzeta,"diacylglycerol kinase, zeta",4,3,
DHCR7,SLOS,7-dehydrocholesterol reductase,10,7,
DIP2A,DIP2; C21orf106,DIP2 disco-interacting protein 2 homolog A (Drosophila),31,7,
DISC1,SCZD9; C1orf136,disrupted in schizophrenia 1,178,25,
DLG1,"DKFZp761P0818, DKFZp781B0426, DLGH1, SAP-97, SAP97, dJ1061C18.1.1, hdlg","discs, large homolog 1 (Drosophila)",18,12,
DLG4,"FLJ97752, FLJ98574, PSD95, SAP-90, SAP90","DLG4discs, large homolog 4 (Drosophila)",127,32,
Dlgap2,DAP-2; PSD-95/SAP90-binding protein 2; SAP90/PSD-95-associated protein 2; SAPAP2,Disks large-associated protein 2,11,7,
DLX1,N/A,distal-less homeobox 1,2,1,
DLX2,TES1; TES-1,distal-less homeobox 2,20,11,
DLX6,N/A,distal-less homeobox 6,2,2,
DMD,BMD; CMD3B; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272,dystrophin,70,37,
DMPK,"DM, DM1, DM1PK, DMK, MDPK, MT-PK",dystrophia myotonica-protein kinase,18,13,
DMXL2,RC3,Dmx-like 2,29,2,
DNM1L,DLP1; DRP1; DVLP; EMPF; VPS1; DYMPLE; HDYNIV; DYNIV-11,dynamin 1-like,16,5,
DOCK4,,dedicator of cytokinesis 4,9,2,
DPP10,"DPL2, DPPY, DPRP3",dipeptidyl-peptidase 10 (non-functional),3,3,
DPP6,"DPPX, FLJ55680, MGC46605, VF2",dipeptidyl-peptidase 6,6,5,
DPYD,"DHP, DHPDHASE, DPD, MGC132008, MGC70799",dihydropyrimidine dehydrogenase,7,5,
DRD1,DADR; DRD1A,dopamine receptor D1,3,2,
DRD2,"D2DR, D2R",dopamine receptor D2,45,28,
DRD3,D3DR; ETM1; FET1,dopamine receptor D3,8,5,
DSCAM,CHD2,Down syndrome cell adhesion molecule,8,6,
DUSP15,"C20orf57, VHY",dual specificity phosphatase 15,2,1,
DVL1,DVL; DVL1L1,"dishevelled, dsh homolog 1 (Drosophila)",4,4,
DVL3,KIAA0208,"dishevelled, dsh homolog 3 (Drosophila)",27,7,
DYDC1,DPY30D1,DPY30 domain-containing protein 1,13,2,
DYRK1A,MNB; DYRK; HP86; MNBH; MRD7; DYRK1,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,55,21,
EHMT1,"RP11-188C12.1, EUHMTASE1, Eu-HMTase1, FP13812, GLP, GLP1, KMT1D, bA188C12.1",euchromatic histone-lysine N-methyltransferase 1,5013,18,
EIF4E,"CBP, EIF4E1, EIF4EL1, EIF4F, MGC111573",eukaryotic translation initiation factor 4E,44,20,
EIF4EBP2,"4EBP2, PHASII",eukaryotic translation initiation factor 4E binding protein 2,9,5,
ELAVL2,HUB; HELN1; HEL-N1,"ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B)",167,4,
EML1,"ELP79, EMAP, EMAPL, FLJ45033, HuEMAP",echinoderm microtubule associated protein like 1,11,3,
EN2,tcag7.568,engrailed homeobox 2,10,7,
EP300,p300; KAT3B; EP300,E1A binding protein p300,16,9,
EP400,P400; CAGH32; TNRC12,E1A binding protein p400,56,26,
EPC2,EPC-LIKE,enhancer of polycomb homolog 2 (Drosophila),25,9,
EPHB2,"CAPB, DRT, EK5, EPHT3, ERK, Hek5, PCBC, Tyro5",EPH receptor B2,6,4,
ERBB2IP,"ERBIN, LAP2",erbb2 interacting protein,25,6,
ERBB4,HER4; p180erbB4,v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian),2,2,
ERG,p55; erg-3,v-ets erythroblastosis virus E26 oncogene homolog (avian),1,1,
ERMN,,Ermin,3,3,
ESR1,"RP1-130E4.1, DKFZp686N23123, ER, ESR, ESRA, Era, NR3A1",estrogen receptor 1,16,11,
ESR2,Erb; ESRB; ESTRB; NR3A2; ER-BETA; ESR-BETA,estrogen receptor 2 (ER beta),11,8,
EXOC5,SEC10; HSEC10; SEC10P; PRO1912; SEC10L1,exocyst complex component 5,42,4,
EXOC6,SEC15; EXOC6A; SEC15L; Sec15p; SEC15L1; SEC15L3,exocyst complex component 6,22,2,
EXT1,EXT; LGS; TTV; LGCR; TRPS2,exostosin 1,27,8,
FABP5,"E-FABP, EFABP, PA-FABP, PAFABP",fatty acid binding protein 5 (psoriasis-associated),3,3,
Fabp7,Brain lipid-binding protein; BLBP; Brain-type fatty acid-binding protein; B-FABP; Fatty acid-binding protein 7; Mammary-derived growth inhibitor related,"Fatty acid-binding protein, brain",3,3,
FAN1,KMIN; MTMR15; KIAA1018,FANCD2/FANCI-associated nuclease 1,12,1,
FAT1,FAT; ME5; CDHF7; CDHR8; hFat1,FAT tumor suppressor homolog 1 (Drosophila),79,15,
FBXO33,Fbx33; BMND12; c14_5247,F-box protein 33,8,6,
Fbxo40,Muscle disease-related protein,F-box only protein 40,6,2,
Fezf2,Forebrain embryonic zinc finger-like protein 2; Zinc finger protein 312; Zinc finger protein Fez-like,Fez family zinc finger protein 2,4,3,
FHIT,"AP3Aase, FRA3B",fragile histidine triad gene,14,10,
FMR1,POF; FMRP; POF1; FRAXA; MGC87458,fragile X mental retardation 1,9286,58,
FOXG1,BF1; BF2; QIN; FKH2; HBF2; HFK1; HFK2; HFK3; KHL2; FHKL3; FKHL1; FKHL2; FKHL3; FKHL4; HBF-1; HBF-2; HBF-3; FOXG1A; FOXG1B; FOXG1C; HBF-G2,forkhead box G1,34,19,
FOXP1,QRF1; 12CC4; hFKH1B; HSPC215,forkhead box P1,153,26,
FOXP2,"CAGH44, DKFZp686H1726, SPCH1, TNRC10",forkhead box P2,307,15,
FRK,GTK; RAK; PTK5,fyn-related kinase,10,8,
GABRA1,"ECA4, EJM, EJM5","gamma-aminobutyric acid (GABA) A receptor, alpha 1",4,4,
GABRA4,GABA(A) receptor subunit alpha-4,Gamma-aminobutyric acid receptor subunit alpha-4,8,6,
GABRB1,GABA(A) receptor subunit beta-1,"gamma-aminobutyric acid (GABA) A receptor, beta 1",6,5,
GABRB3,"ECA5, MGC9051","gamma-aminobutyric acid (GABA) A receptor, beta 3",29,19,
Gabrq,THETA,"gamma-aminobutyric acid (GABA) A receptor, theta",1,1,
GADD45B,"Myeloid differentiation primary response protein MyD118, Negative growth regulatory protein MyD118",Growth arrest and DNA damage-inducible protein GADD45 beta,17,2,
GALNT13,"FLJ16031, FLJ41157, GalNAc-T13, H_NH0187G20.1, KIAA1918, MGC119459, MGC119461, WUGSC:H_NH0187G20.1",UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13),3,2,
GAP43,"B-50, PP46",growth associated protein 43,33,5,
GIGYF1,GYF1; PERQ1,GRB10 interacting GYF protein 1,12,10,
GLO1,GLYI; GLOD1,glyoxalase I,11,6,
GNAS,NESP55,Neuroendocrine secretory protein 55,20,6,
GNB1L,GY2; FKSG1; WDR14; WDVCF; DGCRK3,"guanine nucleotide binding protein (G protein), beta polypeptide 1-like",14,5,
GPHN,GPH; GEPH; HKPX1; GPHRYN,gephyrin,45,23,
GPR37,"EDNRBL, PAELR, hET(B)R-LP",G protein-coupled receptor 37 (endothelin receptor type B-like),34,12,
GPX1,GPXD; GSHPX1,glutathione peroxidase 1,3,3,
GREM1,DRM; PIG2; DAND2; IHG-2; GREMLIN; CKTSF1B1,"gremlin 1, DAN family BMP antagonist",2,2,
GRID2,GluR-delta-2; gluR delta-2 subunit; glutamate receptor delta-2 subunit,"glutamate receptor, ionotropic, delta 2",17,3,
GRIK2,EAA4; GLR6; MRT6; GLUK6; GLUR6; GluK2,"glutamate receptor, ionotropic, kainate 2",29,18,
GRIN1,NR1; MRD8; GluN1; NMDA1; NMDAR1,"glutamate receptor, ionotropic, N-methyl D-aspartate 1",65,7,
GRIN2A,"Glutamate [NMDA] receptor subunit epsilon-1, N-methyl D-aspartate receptor subtype 2A,  NMDAR2A,  NR2A,  hNR2A","Glutamate receptor ionotropic, NMDA 2A",9,7,
GRIN2B,"GluN2B, MRD6, NMDAR2B, NR2B, hNR3","glutamate receptor, ionotropic, N-methyl D-aspartate 2B",77,57,
GRIP1,GRIP,glutamate receptor interacting protein 1,82,66,
GRM5,"GPRC1E, MGLUR5, mGlu5","glutamate receptor, metabotropic 5",38,25,
GRPR,"GRP-preferring bombesin receptor, GRP-R",gastrin-releasing peptide receptor,56,4,
GSK3B,"Serine/threonine-protein kinase GSK3B, GSK-3 beta",glycogen synthase kinase 3 beta,26,16,
GSTM1,"GST HB subunit 4, GST class-mu 1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4",Glutathione S-transferase Mu 1,6,4,
GTF2I,WBS; DIWS; SPIN; IB291; BAP135; BTKAP1; TFII-I; WBSCR6; GTFII-I,general transcription factor IIi,102,54,
HCFC1,CFF; HCF1; HFC1; MRX3; VCAF; HCF-1,host cell factor C1 (VP16-accessory protein),17,9,
HCN1,BCNG1; HAC-2; BCNG-1; EIEE24,hyperpolarization activated cyclic nucleotide-gated potassium channel 1,11,6,
HDAC4,HD4; AHO3; BDMR; HDACA; HA6116; HDAC-4; HDAC-A; KIAA0288,histone deacetylase 4,52,23,
HDAC6,HD6; JM21,histone deacetylase 6,10,3,
HEPACAM,"GlialCAM, MLC2A, MLC2B",hepatic and glial cell adhesion molecule,8,7,
HERC2,jdf2; p528; SHEP1; D15F37S1,HECT and RLD domain containing E3 ubiquitin protein ligase 2,73,24,
HLA-A,HLAA,"major histocompatibility complex, class I, A",18,6,
HLAA,,itted name: <h1>MHC class I antigen HLA-A,3,3,
HMGN1,HMG14,high mobility group nucleosome binding domain 1,35,29,
HOMER1,HOMER; SYN47; Ves-1; HOMER1A; HOMER1B; HOMER1C,homer homolog 1 (Drosophila),61,24,
HOXA1,BSAS; HOX1; HOX1F,homeobox A1,338,15,
HOXB1,"HCFP3, HOX2, HOX2I, Hox-2.9",homeobox B1,1,1,
HRAS,"C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1",v-Ha-ras Harvey rat sarcoma viral oncogene homolog,43,9,
HSD11B1,"11-DH, 11-beta-HSD1, HDL, HSD11, HSD11B, HSD11L, SDR26C1",hydroxysteroid (11-beta) dehydrogenase 1,13,6,
HTR1B,S12; 5-HT1B; HTR1D2; HTR1DB; 5-HT1DB,"5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled",5,4,
HTR2A,"5-HT2A, HTR2","5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled",3,2,
HTR3C,Serotonin receptor 3C,5-hydroxytryptamine receptor 3C,42,2,
HUWE1,MULE; Ib772; LASU1; UREB1; HECTH9; URE-B1; ARF-BP1; HSPC272,"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase",5,5,
ICA1,"ICA69, ICAp69","islet cell autoantigen 1, 69kDa",14,6,
IL1RAPL1,"IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2",interleukin 1 receptor accessory protein-like 1,7,7,
IMMP2L,IMP2-like protein,Mitochondrial inner membrane protease subunit 2,3,2,
INPP1,,Inositol polyphosphate 1-phosphatase,12,4,
ITGB3,GT; CD61; GP3A; BDPLT2; GPIIIa,"integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)",51,40,
Jakmip1,GABA-B receptor-binding protein; Multiple alpha-helices and RNA-linker protein 1; Marlin-1,Janus kinase and microtubule-interacting protein 1,43,1,
JMJD1C,"DKFZp761F0118, FLJ14374, KIAA1380, RP11-10C13.2, TRIP8",jumonji domain containing 1C,13,10,
KAT2B,"CAF, P, P/CAF, PCAF",K(lysine) acetyltransferase 2B,28,5,
KATNAL2,"p60 katanin-like 2, Katanin p60 subunit A-like 2",katanin p60 subunit A-like 2,3,1,
KCND2,RK5; KV4.2,"potassium voltage-gated channel, Shal-related subfamily, member 2",23,13,
KCNJ10,"BIRK-10, KCNJ13-PEN, KIR1.2, KIR4.1, SESAME","potassium inwardly-rectifying channel, subfamily J, member 10",21,14,
KCNMA1,"RP11-443A13.1, BKTM, DKFZp686K1437, KCa1.1, MGC71881, MaxiK, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, mSLO1","potassium large conductance calcium-activated channel, subfamily M, alpha member 1",26,17,
KCNQ2,EBN; BFNC; EBN1; ENB1; BFNS1; EIEE7; HNSPC; KV7.2; KCNA11; KVEBN1,"potassium voltage-gated channel, KQT-like subfamily, member 2",10,6,
KCNQ3,EBN2; BFNC2; KV7.3,"potassium voltage-gated channel, KQT-like subfamily, member 3",5,4,
KCNT1,"EIEE14, ENFL5, KCa4.1, SLACK, Slo2.2, bA100C15.2","potassium channel, subfamily T, member 1",3,2,
KCTD13,PDIP1; FKSG86; POLDIP1; hBACURD1,potassium channel tetramerisation domain containing 13,40,13,
KDM5B,"CT31, FLJ10538, FLJ12459, FLJ12491, FLJ16281, FLJ23670, JARID1B, PLU-1, PLU1, PUT1, RBBP2H1A",lysine (K)-specific demethylase 5B,97,28,
KDM5C,MRXJ; SMCX; MRX13; MRXSJ; XE169; MRXSCJ; JARID1C; DXS1272E,lysine (K)-specific demethylase 5C,17,4,
KDM6B,"JmjC domain-containing protein 3, Jumonji domain-containing protein 3, Lysine demethylase 6B",Lysine-specific demethylase 6B,14,7,
KHDRBS2,SLM1; SLM-1; bA535F17.1,"KH domain containing, RNA binding, signal transduction associated 2",106,8,
KHDRBS3,"Etle, SALP, SLM-2, SLM2, T-STAR, TSTAR, etoile","KH domain containing, RNA binding, signal transduction associated 3",15,9,
KIAA1586,FLJ30162,KIAA1586,5,3,
KIF5C,"CDCBM2, KINN, NKHC, NKHC-2, NKHC2",kinesin family member 5C,12,4,
KLC2,KLC 2,kinesin light chain 2,22,5,
KMT2A,HRX; MLL; TRX1; ALL-1; CXXC7; HTRX1; MLL1A; WDSTS; MLL/GAS7; TET1-MLL,lysine (K)-specific methyltransferase 2A,3,2,
KMT2C,"HALR, MLL3",lysine methyltransferase 2C,2,1,
KMT2E,"HDCMC04P, MLL5, NKp44L",lysine (K)-specific methyltransferase 2E,32,2,
KPTN,2E4; MRT41,kaptin (actin binding protein),30,3,
LAMB1,CLM,"laminin, beta 1",18,7,
LEP,LEP1,Beta-secretase 1,1,1,
LMX1B,"LMX1.2, NPS1","LIM homeobox transcription factor 1, beta",27,10,
LRP2,"DBS, GP330",low density lipoprotein receptor-related protein 2,78,35,
LRPPRC,LSFC; GP130; LRP130; CLONE-23970,leucine-rich pentatricopeptide repeat containing,3,3,
LRRC1,LANO; dJ523E19.1,leucine rich repeat containing 1,16,7,
LZTS2,LAPSER1; RP11-108L7.8; KIAA1813,"leucine zipper, putative tumor suppressor 2",235,10,
MACROD2,C20orf133,MACRO domain containing 2,4,3,
MAGED1,"PRO2292, DLXIN-1, NRAGE","melanoma antigen family D, 1",34,7,
MAGEL2,nM15; NDNL1,MAGE-like 2,7,4,
MAOA,MAO-A,monoamine oxidase A,4,3,
MAP2,MAP-2,Microtubule-associated protein 2,6,2,
MAPK1,"ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk",mitogen-activated protein kinase 1,7,7,
MAPK12,ERK3; ERK6; SAPK3; PRKM12; SAPK-3; P38GAMMA,mitogen-activated protein kinase 12,6,4,
MAPK3,"ERK1, HS44KDAP, HUMKER1A, MGC20180, P44ERK1, P44MAPK, PRKM3",mitogen-activated protein kinase 3,31,9,
MAPK8IP2,IB2; JIP2; PRKM8IPL,mitogen-activated protein kinase 8 interacting protein 2,6,3,
MARK1,MARK; Par1c; Par-1c,MAP/microtubule affinity-regulating kinase 1,10,8,
MBD1,"CXXC3, PCM1, RFT",methyl-CpG binding domain protein 1,32,9,
MBD3,Methyl-CpG-binding protein MBD3,methyl-CpG binding domain protein 3,47,17,
MBD4,MED1,methyl-CpG binding domain protein 4,9,8,
MBD5,"FLJ11113, FLJ30517, KIAA1461, MRD1",methyl-CpG binding domain protein 5,20,6,
MC4R,,melanocortin 4 receptor,1,1,
MCPH1,"BRIT1, FLJ12847, MCT",microcephalin 1,12,8,
MDGA2,"UNQ8188/PRO23197, MAMDC1, c14_5286",MAM domain containing glycosylphosphatidylinositol anchor 2,1,1,
MECP2,"AUTSX3, DKFZp686A24160, MRX16, MRX79, MRXS13, MRXSL, PPMX, RS, RTS, RTT",methyl CpG binding protein 2 (Rett syndrome),522,117,
MED13L,THRAP2; TRAP240L; PROSIT240,mediator complex subunit 13-like,21,7,
MEF2C,DEL5q14.3; C5DELq14.3,myocyte enhancer factor 2C,14,13,
MET,"AUTS9, HGFR, RCCP2, c-Met",met proto-oncogene (hepatocyte growth factor receptor),142,49,
MIB1,"DIP-1, DIP1, LVNC7, MIB, ZZANK2, ZZZ6",mindbomb E3 ubiquitin protein ligase 1,364,5,
MKL2,"Megakaryoblastic leukemia 2, Myocardin-related transcription factor B,  MRTF-B",MKL/myocardin-like protein 2,5,3,
MLL5,MLL5; NKp44L; HDCMC04P,lysine (K)-specific methyltransferase 2E,12,5,
MSN,Membrane-organizing extension spike protein,moesin,88,49,
MSR1,"CD204, SCARA1, SR-A, SRA, phSR1, phSR2",macrophage scavenger receptor 1,19,7,
MTF1,ZRF; MTF-1,metal-regulatory transcription factor 1,3,3,
MTMR10,N/A,myotubularin related protein 10,3,2,
MTOR,FRAP; FRAP1; FRAP2; RAFT1; RAPT1,mechanistic target of rapamycin (serine/threonine kinase),41,11,
MTX2,Mitochondrial outer membrane import complex protein 2,metaxin 2,10,3,
NAA15,Ga19; NATH; NARG1; TBDN100,"N(alpha)-acetyltransferase 15, NatA auxiliary subunit",14,2,
NBEA,"RP11-270C18.1, BCL8B, LYST2",neurobeachin,120,6,
NCKAP1,HEM2; NAP1; NAP125; p125Nap1,NCK-associated protein 1,43,17,
NCKAP5L,"FP1193, FLJ36581, KIAA1602, MGC129863",NCK-associated protein 5-like,4,4,
NDNL2,HCA4; NSE3; MAGEG1; MAGEL3; NSMCE3,necdin-like 2,8,3,
NDUFA5,B13; NUFM; UQOR13; CI-13kB; CI-13KD-B,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa",17,10,
NELL1,"FLJ45906, IDH3GL, NRP1",NEL-like 1 (chicken),22,3,
NEO1,NGN; IGDCC2,neogenin 1,10,6,
NF1,"DKFZp686J1293, FLJ21220, NFNS, VRNF, WSS",neurofibromin 1,40,19,
NINL,NLP; dJ691N24.1; FLJ11792; KIAA0980,ninein-like,43,4,
NIPBL,"CDLS, CDLS1, IDN3, IDN3-B, Scc2",Nipped-B homolog (Drosophila),18,13,
NLGN1,"KIAA1070, MGC45115, NL1",neuroligin 1,21,14,
NLGN2,N/A,neuroligin 2,18,9,
NLGN3,HNL3; KIAA1480,neuroligin 3,95,14,
NLGN4X,HLNX; HNLX; NLGN; HNL4X; NLGN4; ASPGX2; AUTSX2; KIAA1260; MGC22376,"neuroligin 4, X-linked",5,5,
NOS1,NOS; bNOS; nNOS; IHPS1; N-NOS; NC-NOS,nitric oxide synthase 1 (neuronal),12,8,
NOS1AP,"6330408P19Rik, CAPON, MGC138500",nitric oxide synthase 1 (neuronal) adaptor protein,34,10,
NOS2,"HEP-NOS, INOS, NOS, NOS2","nitric oxide synthase 2, inducible",41,33,
NPAS2,MOP4; PASD4; bHLHe9,neuronal PAS domain protein 2,14,5,
NRCAM,N/A,neuronal cell adhesion molecule,6,5,
NRG1,"Acetylcholine receptor-inducing activity,  ARIA, Breast cancer cell differentiation factor p45, Glial growth factor, Heregulin,  HRG, Neu differentiation factor, Sensory and motor neuron-derived factor","Pro-neuregulin-1, membrane-bound isoform",41,4,
NRP2,"NP2, NPN2, PRO2714, VEGF165R2",neuropilin 2,43,24,
NRXN1,"DKFZp313P2036, FLJ35941, Hs.22998, KIAA0578, PTHSL2",neurexin 1,76,29,
NRXN2,"Neurexin II-alpha, Neurexin-2-alpha",Neurexin-2,12,9,
NRXN3,C14orf60,neurexin 3,34,7,
NSD1,"ARA267, KMT3B, SOTOS, STO",nuclear receptor binding SET domain protein 1,383,18,
NTNG1,"UNQ571/PRO1133, KIAA0976, Lmnt1",netrin G1,5,4,
NTRK1,MTC; TRK; TRK1; TRKA; Trk-A; p140-TrkA,"neurotrophic tyrosine kinase, receptor, type 1",2,2,
NTRK3,TRKC; gp145(trkC),"neurotrophic tyrosine kinase, receptor, type 3",34,7,
ODF3L2,"C19orf19, FLJ40059, MGC129962, MGC129963",outer dense fiber of sperm tails 3-like 2,6,2,
OGT,HRNT1; O-GLCNAC,O-linked N-acetylglucosamine (GlcNAc) transferase,15,6,
OPHN1,"RP6-201G10.1, ARHGAP41, MRX60, OPN1",oligophrenin 1,9,6,
OTUD7A,OTUD7; C15orf16; C16ORF15; CEZANNE2,OTU domain containing 7A,1,1,
OXT,"MGC126890, MGC126892, OT, OT-NPI","oxytocin, prepropeptide",8,4,
OXTR,OT-R,oxytocin receptor,13,8,
PAFAH1B1,MDS; LIS1; LIS2; MDCR; PAFAH,"platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)",14,7,
PAH,PH; PKU; PKU1,phenylalanine hydroxylase,4,3,
PARK2,"KB-152G3.1, AR-JP, LPRS2, PDJ, PRKN","parkinson protein 2, E3 ubiquitin protein ligase (parkin)",105,51,
PAX6,AN; AN2; MGDA; WAGR; D11S812E; MGC17209,paired box 6,347,4,
PCDH10,"DKFZp761O2023, KIAA1400, MGC133344, OL-PCDH, PCDH19",protocadherin 10,10,4,
PCDH19,EFMR; EIEE9,protocadherin 19,5,4,
PCDH9,RP11-335P18.3,protocadherin 9,7,5,
PCDHGA11,PCDH-GAMMA-A11,"protocadherin gamma subfamily A, 11",10,2,
PER1,PER; hPER; RIGUI,period homolog 1 (Drosophila),46,12,
PHF2,GRC5; JHDM1E; CENP-35,PHD finger protein 2,5,5,
PHF8,JHDM1F; MRXSSD; ZNF422,PHD finger protein 8,35,18,
PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma,  PtdIns-3-kinase subunit p110-gamma,  p110gamma, Phosphoinositide-3-kinase catalytic gamma polypeptide, Serine/threonine protein kinase PIK3CG (EC:2.7.11.1), p120-PI3K","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",2,2,
PITX1,BFT; CCF; POTX; PTX1; LBNBG,paired-like homeodomain 1,23,6,
PLAUR,CD87; UPAR; URKR; U-PAR,"plasminogen activator, urokinase receptor",108,25,
PLN,"RP3-509L4.2, CMD1P, PLB",phospholamban,13,11,
PLXNA4,"FAYV2820, PLEXA4A, PLXNA4B, PRO34003, PLXNA4",plexin A4,7,4,
POGZ,SUHW5; ZNF635; ZNF280E; ZNF635m,pogo transposable element with ZNF domain,38,21,
POMGNT1,"RP11-322N21.3, DKFZp761B182, FLJ20277, GNTI.2, MDDGA3, MDDGB3, MDDGC3, MEB, MGAT1.2","protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase",19,7,
PON1,ESA; PON; MVCD5,paraoxonase 1,10,4,
POU3F2,BRN2; OCT7; OTF7; OTF-7; POUF3; brn-2; oct-7; N-Oct3,POU class 3 homeobox 2,1,1,
PPFIA1,LIP1; LIP.1; LIPRIN,"protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1",16,3,
PPP1R1B,"DARPP-32, DARPP32","protein phosphatase 1, regulatory (inhibitor) subunit 1B",19,12,
PREX1,KIAA1415,"Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein",1,1,
PRICKLE1,RILP; EPM1B,prickle homolog 1 (Drosophila),13,2,
PRICKLE2,EPM5,prickle homolog 2 (Drosophila),17,5,
PRKCB,PKCB; PRKCB1; PRKCB2; PKC-beta,"protein kinase C, beta",37,35,
PRKCB1,PKCB; PRKCB1; PRKCB2; PKC-beta,"protein kinase C, beta",35,13,
PRKCB2,PKCB; PRKCB1; PRKCB2; PKC-beta,"protein kinase C, beta",36,23,
PSD3,"EFA6R, HCA67",pleckstrin and Sec7 domain containing 3,8,7,
PTCHD1,"FLJ30296, MGC149798",patched domain containing 1,1,1,
PTEN,BZS; DEC; GLM2; MHAM; TEP1; MMAC1; PTEN1; 10q23del; MGC11227,phosphatase and tensin homolog,184,104,
PTGS2,"Cyclooxygenase-2, COX-2",Prostaglandin G/H synthase 2,2,2,
PTK7,CCK4; CCK-4,protein tyrosine kinase 7,3,1,
PTPMT1,MOSP; PLIP; DUSP23; PNAS-129,"protein tyrosine phosphatase, mitochondrial 1",1,1,
PTPN11,"BPTP3, CFC, MGC14433, NS1, PTP-1D, PTP2C, SH-PTP2, SH-PTP3, SHP2","protein tyrosine phosphatase, non-receptor type 11",27,7,
PXDN,PXN; VPO; MG50; PRG2; D2S448; D2S448E,peroxidasin homolog (Drosophila),21,4,
RAB39B,"RP13-228J13.2, MRX72","RAB39B, member RAS oncogene family",29,7,
RAI1,SMS; SMCR,retinoic acid induced 1,15,9,
RAPGEF4,"CAMP-GEFII, CGEF2, EPAC2, Nbla00496",Rap guanine nucleotide exchange factor (GEF) 4,17,10,
RASSF5,RAPL; Maxp1; NORE1; NORE1A; NORE1B; RASSF3,Ras association (RalGDS/AF-6) domain family member 5,18,2,
RB1CC1,"CC1, FIP200",RB1-inducible coiled-coil 1,40,12,
RBFOX1,"A2BP1, FOX-1, FOX1, HRNBP1","RNA binding protein, fox-1 homolog (C. elegans) 1",494,23,
REEP3,"RP11-439F7.1, C10orf74, MGC87479",receptor accessory protein 3,3,3,
RELN,"LIS2, PRO1598, RL",reelin,12,9,
RFWD2,"RP11-318C24.3, COP1, FLJ10416, RNF200",ring finger and WD repeat domain 2,60,11,
RGS7,RGS7,regulator of G-protein signaling 7,6,4,
RHOV,CHP; ARHV; WRCH2,ras homolog family member V,2,2,
RHOXF1,OTEX; PEPP1,"Rhox homeobox family, member 1",2,2,
RIMS1,RIM; RIM1; CORD7; RAB3IP2,regulating synaptic membrane exocytosis 1,14,6,
RIMS3,"RP4-739H11.2, KIAA0237, NIM3, RIM3",regulating synaptic membrane exocytosis 3,3,3,
ROBO1,SAX3; DUTT1,"roundabout, axon guidance receptor, homolog 1 (Drosophila)",3,3,
ROBO2,SAX3,"roundabout, axon guidance receptor, homolog 2 (Drosophila)",5,2,
RPL10,"XX-FW83563B9.1, DKFZp686J1851, DXS648, DXS648E, FLJ23544, FLJ27072, NOV, QM",ribosomal protein L10,15,9,
RPS6KA2,"RP1-168L15.2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, pp90RSK3","ribosomal protein S6 kinase, 90kDa, polypeptide 2",18,6,
SATB2,Special AT-rich sequence-binding protein 2,SATB homeobox 2,51,26,
SBF1,MTMR5; CMT4B3; DENND7A,SET binding factor 1,18,4,
SCN1A,Sodium channel protein brain I subunit alpha; Sodium channel protein type I subunit alpha; Voltage-gated sodium channel subunit alpha Nav1.1,Sodium channel protein type 1 subunit alpha,3,3,
SCN2A,"BFIC3, EIEE11, HBA, HBSCI, HBSCII, NAC2, Na(v)1.2, Nav1.2, SCN2A1, SCN2A2","sodium channel, voltage-gated, type II, alpha subunit",17,12,
SCN5A,HB1; HB2; HH1; IVF; VF1; HBBD; ICCD; LQT3; SSS1; CDCD2; CMD1E; CMPD2; PFHB1; Nav1.5,"sodium channel, voltage-gated, type V, alpha subunit",5,3,
SCN8A,"CERIII, CIAT, EIEE13, MED, NaCh6, Nav1.6, PN4","sodium channel, voltage gated, type VIII, alpha subunit",14,12,
SDC2,"HSPG, HSPG1, SYND2",syndecan 2,68,10,
SEMA5A,semF; SEMAF; FLJ12815,"sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A",2,2,
SERPINE1,"PAI, PAI-1, PAI1, PLANH1","serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",3,3,
SETBP1,SEB,SET binding protein 1,17,7,
SETD2,"HSPC069, FLJ16420, FLJ22472, FLJ23184, FLJ45883, FLJ46217, HBP231, HIF-1, HIP-1, HYPB, KIAA1732, KMT3A, SET2, p231HBP",SET domain containing 2,26,10,
SETD5,N/A,SET domain containing 5,17,9,
SEZ6L2,PSK,Seizure 6-like protein 2,7,3,
SH3KBP1,"RP11-345L8.1, CD2BP3, CIN85, GIG10, HSB-1, HSB1, MIG18",SH3-domain kinase binding protein 1,33,3,
SHANK1,SSTRIP; SPANK-1; synamon,SH3 and multiple ankyrin repeat domains 1,20,15,
SHANK2,"AUTS17, CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3",SH3 and multiple ankyrin repeat domains 2,27,18,
SHANK3,"DEL22q13.3, KIAA1650, PROSAP2, PSAP2, SPANK-2",SH3 and multiple ankyrin repeat domains 3,183,25,
SIN3A,"DKFZp434K2235, FLJ90319, KIAA0700","SIN3 homolog A, transcription regulator (yeast)",25,9,
Slc12a5,"Electroneutral potassium-chloride cotransporter 2, K-Cl cotransporter 2, hKCC2, Neuronal K-Cl cotransporter",Solute carrier family 12 member 5,7,5,
SLC16A3,"MCT 3, MCT 4, MCT-3, MCT-4, MCT3, MCT4","solute carrier family 16, member 3 (monocarboxylic acid transporter 4)",8,6,
SLC1A1,EAAC1; EAAT3,"solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1",38,12,
SLC25A12,AGC1; ARALAR,"solute carrier family 25 (aspartate/glutamate carrier), member 12",11,7,
SLC38A10,PP1744,"solute carrier family 38, member 10",8,4,
SLC4A10,"NBCn2, NCBE","solute carrier family 4, sodium bicarbonate transporter, member 10",3,3,
SLC6A3,DAT; DAT1,"solute carrier family 6 (neurotransmitter transporter, dopamine), member 3",17,11,
SLC6A4,HTT; 5HTT; OCD1; SERT; 5-HTT; SERT1; hSERT; 5-HTTLPR,"solute carrier family 6 (neurotransmitter transporter, serotonin), member 4",7,5,
SLC6A8,"CRT, CRTR, CT1, MGC87396","solute carrier family 6 (neurotransmitter transporter, creatine), member 8",9,4,
SLC9A6,MRSA; NHE6; KIAA0267,"solute carrier family 9 (sodium/hydrogen exchanger), member 6",32,4,
SLC9A9,"Nbla00118, AUTS16, FLJ35613, NHE9","solute carrier family 9 (sodium/hydrogen exchanger), member 9",3,2,
Slit3,Slit-3; Multiple epidermal growth factor-like domains protein 5; Multiple EGF-like domains protein 5,Slit homolog 3 protein,1,1,
SLITRK5,"KIAA0918, LRRC11",SLIT and NTRK-like protein 5,7,3,
SMARCA2,BRM; SNF2; SWI2; hBRM; NCBRS; Sth1p; BAF190; SNF2L2; SNF2LA; hSNF2a; FLJ36757; MGC74511,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",24,7,
SMG6,EST1A; SMG-6; C17orf31; hSMG5/7a,"smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans)",10,5,
SNAP25,SNAP,Synaptosomal-associated protein 25,15,8,
SND1,p100; TDRD11,staphylococcal nuclease and tudor domain containing 1,26,10,
SNRPN,"DKFZp686C0927, DKFZp686M12165, DKFZp761I1912, DKFZp762N022, FLJ33569, FLJ36996, FLJ39265, HCERN3, MGC29886, PWCR, RT-LI, SM-D, SMN, SNRNP-N,?",small nuclear ribonucleoprotein polypeptide N,127,24,
SNTG2,SYN5; G2SYN; MGC133174,"syntrophin, gamma 2",18,6,
SNX14,RGS-PX2; RP11-321N4.2,sorting nexin 14,18,2,
SOD1,ALS; SOD; ALS1; IPOA; hSod1; homodimer,"superoxide dismutase 1, soluble",8,2,
SOX5,L-SOX5; L-SOX5B; L-SOX5F,SRY (sex determining region Y)-box 5,34,8,
SPARCL1,SC1; PIG33,SPARC-like 1 (hevin),5,2,
SRRM4,"KIAA1853, MU-MB-2.76, nSR100",serine/arginine repetitive matrix 4,34,3,
ST7,"DKFZp762O2113, ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7",suppression of tumorigenicity 7,25,4,
STK39,DCHT; PASK; SPAK,serine threonine kinase 39,13,5,
STX1A,STX1; HPC-1; P35-1; SYN1A,syntaxin 1A (brain),28,11,
SUCLG2,GBETA,"succinate-CoA ligase, GDP-forming, beta subunit",10,6,
SUV420H1,"CGI-85, CGI85, KMT5B",suppressor of variegation 4-20 homolog 1 (Drosophila),10,9,
SYN1,"Brain protein 4.1, Synapsin I",Synapsin-1,12,6,
SYN3,N/A,synapsin III,2,2,
SYNE1,"RP1-130E4.2, 8B, ARCA1, C6orf98, CPG2, DKFZp781J13156, EDMD4, FLJ30878, FLJ41140, KIAA0796, KIAA1262, KIAA1756, MYNE1, SCAR8, dJ45H2.2","spectrin repeat containing, nuclear envelope 1",34,27,
SYNGAP1,"DASS-97D12.6, DKFZp761G1421, KIAA1938, MRD5, RASA1, RASA5, SYNGAP",synaptic Ras GTPase activating protein 1,19,13,
SYT17,,synaptotagmin XVII,21,5,
SYT3,sytIII; AI385753,synaptotagmin III,19,8,
TAF1,"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, N-TAF1, NSCL2, OF, P250, TAF2A, TAFII250, XDP","TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa",6,4,
TBC1D5,N/A,"TBC1 domain family, member 5",14,8,
TBL1X,EBI; TBL1; SMAP55,transducin (beta)-like 1X-linked,29,10,
TBL1XR1,C21; DC42; IRA1; TBLR1,transducin (beta)-like 1 X-linked receptor 1,49,28,
TBR1,"TBR-1, TES-56","T-box, brain, 1",82,20,
TCF4,E2-2; ITF2; PTHS; SEF2; ITF-2; SEF-2; TCF-4; SEF2-1; SEF2-1A; SEF2-1B; bHLHb19,transcription factor 4,167,7,
TCF7L2,TCF4; TCF-4,"transcription factor 7-like 2 (T-cell specific, HMG-box)",42,19,
TDO2,TO; TDO; TPH2; TRPO,"tryptophan 2,3-dioxygenase",23,6,
TERF2,"TRBF2, TRF2",telomeric repeat binding factor 2,147,6,
TH,"Tyrosine 3-hydroxylase,  TH",Tyrosine 3-monooxygenase,10,2,
THRA,AR7; EAR7; ERBA; CHNG6; ERBA1; NR1A1; THRA1; THRA2; ERB-T-1; c-ERBA-1,"thyroid hormone receptor, alpha",10,5,
TLK2,HsHPK; PKU-ALPHA,tousled-like kinase 2,11,2,
TMLHE,"AUTSX6, BBOX2, TMLD, TMLH, TMLHED, XAP130","trimethyllysine hydroxylase, epsilon",4,4,
TNRC6B,N/A,trinucleotide repeat containing 6B,35,15,
TOMM20,MAS20; MOM19; TOM20,translocase of outer mitochondrial membrane 20 homolog (yeast),4,1,
TOP1,TOPI,topoisomerase (DNA) I,159,56,
TOP3B,DNA topoisomerase III beta-1,topoisomerase (DNA) III beta,1986,8,
TRIM33,ECTO; PTC7; RFG7; TF1G; TIF1G; TIFGAMMA; TIF1GAMMA,tripartite motif containing 33,15,4,
TRIO,tgat; ARHGEF23,triple functional domain (PTPRF interacting),7,6,
TRIP12,ULF,thyroid hormone receptor interactor 12,30,17,
TRPC6,"Transient receptor protein 6,  TRP-6",Short transient receptor potential channel 6,2,2,
TSC1,"KIAA0243, LAM, MGC86987, TSC",tuberous sclerosis 1,118,33,
TSC2,"FLJ43106, LAM, TSC4",tuberous sclerosis 2,104,58,
TSN,C3PO; RCHF1; TBRBP; TRSLN; BCLF-1; REHF-1,translin,4,3,
TSPAN7,A15; MXS1; CD231; MRX58; CCG-B7; TM4SF2; TALLA-1; TM4SF2b; DXS1692E,tetraspanin 7,6,6,
TTI2,"C8orf41, MRT39",TELO2 interacting protein 2,2,1,
UBE2H,GID3; UBC8; UBCH; UBCH2; E2-20K,ubiquitin-conjugating enzyme E2H,19,8,
UBE3A,"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A",ubiquitin protein ligase E3A,166,40,
UBE3B,ULF,thyroid hormone receptor interactor 12,4,3,
UBE3C,HECTH2,ubiquitin protein ligase E3C,6,5,
UBR5,DD5; EDD; HYD; EDD1,ubiquitin protein ligase E3 component n-recognin 5,15,3,
UPF3B,UPF3X; HUPF3B; MRXS14; RENT3B,UPF3 regulator of nonsense transcripts homolog B (yeast),40,18,
USP7,"HAUSP, TEF1",ubiquitin specific peptidase 7 (herpes virus-associated),41,8,
VASH1,KIAA1036,vasohibin 1,7,3,
VIP,"Peptide histidine valine 42, Intestinal peptide PHM-27Alternative name(s):, Peptide histidine methioninamide 27, Vasoactive intestinal peptide,  VIPAlternative name(s):, Vasoactive intestinal polypeptide",VIP peptides,8,5,
VPS13B,"CHS1, COH1",vacuolar protein sorting 13 homolog B (yeast),14,5,
WAC,Wwp4; BM-016; PRO1741,WW domain containing adaptor with coiled-coil,95,21,
WDFY3,ALFY; ZFYVE25,WD repeat and FYVE domain containing 3,37,12,
WNK3,PRKWNK3,WNK lysine deficient protein kinase 3,4,3,
XPC,"RAD4, XP3, XPCC","xeroderma pigmentosum, complementation group C",56,18,
XPO1,"CRM1, DKFZp686B1823, emb","exportin 1 (CRM1 homolog, yeast)",6,5,
YTHDC2,CAHL,YTH domain containing 2,24,9,
YWHAE,"14-3-3E, FLJ45465, FLJ53559, KCIP-1, MDCR, MDS","tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide",34,13,
ZBTB20,HOF; DPZF; ODA-8S; ZNF288,zinc finger and BTB domain containing 20,18,11,
ZMYND11,BS69; BRAM1; RP11-486H9.1,"zinc finger, MYND-type containing 11",39,23,
ZNF18,HDSG1; KOX11; ZNF535; Zfp535; ZKSCAN6; ZSCAN38,zinc finger protein 18,10,3,
ZNF827,Znf827,zinc finger protein 827,1,1,
AGMO,TMEM195; FLJ16237; MGC131748,alkylglycerol monooxygenase,0,0,
CDH17,"Intestinal peptide-associated transporter HPT-1, LI-cadherin",Cadherin-17,0,0,
CEP41,"JBTS15, TSGA14",centrosomal protein 41kDa,0,0,
HS3ST5,"3OST5, HS3OST5",Heparan sulfate glucosamine 3-O-sulfotransferase 5,0,0,
IL1RAPL2,IL1R9,X-linked interleukin-1 receptor accessory protein-like 2,0,0,
LRFN5,SALM5; FIGLER8; C14orf146,Leucine-rich repeat and fibronectin type-III domain-containing protein 5,0,0,
MYO7A,DFNB2; MYU7A; NSRD2; USH1B; DFNA11; MYOVIIA,Unconventional myosin-VIIa,0,0,
OR1C1,OR1-42; ORL211; TPCR27; HSTPCR27; OR1.5.10,"olfactory receptor, family 1, subfamily C, member 1",0,0,
PECAM1,"EndoCAM, PECAM-1",Platelet endothelial cell adhesion molecule,0,0,
